Search

Your search keyword '"Parra-Cordero M"' showing total 191 results

Search Constraints

Start Over You searched for: Author "Parra-Cordero M" Remove constraint Author: "Parra-Cordero M" Language english Remove constraint Language: english
191 results on '"Parra-Cordero M"'

Search Results

2. EP17.15: Evaluation of clinical and biophysical markers as a screening test for late‐onset pre‐eclampsia between 35 and 38 weeks of gestation.

3. EP14.20: Current experience with laser therapy for Twin–twin transfusion syndrome treatment in university and public hospitals in Chile.

4. OP15.05: First trimester fetal growth: a screening tool for small‐for‐gestational‐age newborns.

5. OC01.03: Uterine artery vasodilation and its impact on maternal and perinatal outcomes in aspirin‐using pregnant women for preterm pre‐eclampsia prevention.

6. EP10.18: Fetal therapy for twin reverse arterial perfusion sequence: experience from two centres in Chile.

10. EP18.18: Development of a multivariate predictive model for Trisomy 21 risk assessment at 20–25 weeks of gestation.

11. EP09.105: Persistent left superior vena cava: prenatal diagnosis and associations.

12. OP15.07: Use of the cardiovascular resistance index to predict labetalol non‐response in the management of hypertensive crisis during pregnancy.

13. OP05.01: Impact of Doppler and gestational age on the prediction of adverse perinatal outcome in fetuses with late‐onset fetal growth restriction.

14. OC06.08: Use of new second trimester craniofacial markers of Trisomy 21 at 20 to 25 weeks screening ultrasound.

17. Quality assessment of fetal middle cerebral and umbilical artery Doppler images using an objective scale within an international randomized controlled trial.

20. VP34.01: Customised Doppler standards for the definition of late fetal growth restriction.

21. EP38.06: Variability in the diagnosis and management of fetal growth restriction across Latin America and the Caribbean.

22. EP01.38: Perinatal outcomes of pregestational hypertension according to blood pressure range at 11–14‐week scan: impact of the 2017 ACC/AHA guidelines.

23. EP18.14: Perinatal outcomes of fetuses diagnosed with Ebstein's anomaly or tricuspid dysplasia: a multicentre case series.

24. EP35.04: Portosystemic shunts associated with severe fetal growth restriction: report of two cases.

25. EP15.02: Perinatal outcomes of fetuses with nuchal translucency > 99th percentile at 11–14 weeks' scan and normal karyotype: a single Chilean institutional study.

26. EP01.39: Concordance analysis of transvaginal and transabdominal uterine artery Doppler assessment at 11 to 14 weeks' scan.

27. EP01.11: Risk of pre‐eclampsia according to blood pressure range at 11–14‐week scan in a very low‐risk population: impact of AHA/ACC 2017 classification.

28. Role of the glucose tolerance test as a predictor of preeclampsia.

29. OP03.05: Mental wellbeing among pregnant and postpartum women during the COVID‐19 pandemic: a large international survey.

30. P19.12: Is first trimester saliva progesterone level associated with spontaneous preterm delivery?

31. EP20.21: Combined predictive model of birthweight at diagnosis of early and late onset pre‐eclampsia.

32. P20.06: Agenesis of the ductus venosus: prenatal diagnosis, perinatal outcomes and systematic review of literature.

34. EP20.19: Role of cerebroplacental ratio in normal growing fetus for the detection of abnormal perinatal outcomes.

35. EP04.02: Ultrasound reference ranges for fetal prenasal thickness and its role as screening test for chromosomal abnormalities at 16–25 weeks of gestation.

36. EP16.21: Fetal diagnosis of anomalous renal vein shunt into azygos vein.

37. EP12.07: Prenatal diagnosis of corrected transposition of great arteries: 13‐case series and systematic review of literature.

38. EP04.15: Reference range of fetal nasal bone and its role for aneuploidy screening 11+0–13+6 weeks in a Chilean population.

39. P17.02: Prenatal diagnosis of neuroblastoma: a report of seven cases and systematic review of literature.

42. OP08.08: Screening of spontaneous preterm delivery by obstetric history and second trimester ultrasound in an unselected Chilean population.

44. OP12.04: Lymphocytes and cytokines pattern as potential markers for screening of pre-eclampsia and fetal growth restriction during the first trimester of pregnancy.

45. OP12.07: Prediction of pre-eclampsia by maternal characteristic and biophysical markers during the first trimester of pregnancy.

46. P14.07: Twin pregnancy: screening test for spontaneous preterm delivery and pre-eclampsia during the first trimester of pregnancy.

48. P16.03: Role of mean blood pressure as screening test for small-for-gestational age without pre-eclampsia during the first trimester of pregnancy.

49. P16.07: Characterisation of immune patterns in pregnancies defined as high- or low-risk according to first trimester uterine artery Doppler.

Catalog

Books, media, physical & digital resources